EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical and Biomarker Predictors of Adverse Left Ventricular Remodeling After First STEMI: Insights into Phenotype Variability Using CMR

Agneta Virbickiene, Vacis Tatarunas iD, Ieva Ciapiene iD, Neda Jonaitiene, Justina Jureviciute, Paulius Bucius iD, Arnoldas Leleika, Ieva Jonauskiene, Liepa Kleizaite iD, Tomas Lapinskas iD, Olivija Dobiliene

Pharmaceuticals · 19.05.2026 · 19 (5) · 794

DOI: 10.3390/ph19050794 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 19.05.2026. Verfasst von Agneta Virbickiene und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cardiology, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Adverse left ventricular remodeling (ALVR) remains an important complication after ST-segment elevation myocardial infarction (STEMI) despite timely reperfusion therapy. Early circulating biomarkers reflecting thromboinflammatory and eicosanoid-related pathways may improve identification of patients at risk of unfavorable remodeling.

Objectives

To investigate whether platelet count, 20-hydroxyeicosatetraenoic acid (20-HETE), 15(S)-hydroxyeicosatetraenoic acid [15(S)-HETE], and NETosis activity measured on the morning after reperfusion therapy are associated with serial cardiac magnetic resonance (CMR)-defined ALVR after first STEMI.

Methods

In this prospective single-center study, 93 patients with first STEMI treated with reperfusion therapy, including primary percutaneous coronary intervention (PCI) in 87 patients and thrombolysis followed by PCI underwent baseline CMR at a median of 4 days after PCI and repeat CMR at 6 months. ALVR was defined as a ≥12% increase in both left ventricular end-diastolic volume and left ventricular end-systolic volume at follow-up. Fasting blood samples obtained on the morning after PCI were used to measure platelet count, 20-HETE, 15(S)-HETE, and NETosis activity. Univariable and multivariable logistic regression and receiver operating characteristic analyses were performed. A secondary exploratory analysis evaluated predictors of absolute improvement in left ventricular ejection fraction (LVEF) of ≥10%.

Results

ALVR occurred in 19 of 93 patients (20.4%). Patients with ALVR had lower platelet count and lower 20-HETE levels at baseline. In the multivariable model, lower platelet count (OR 0.981, 95% CI 0.965–0.996; p = 0.015) and lower 20-HETE (OR 0.985, 95% CI 0.970–1.000; p = 0.047) were independently associated with ALVR, whereas urea was not significant. In receiver operating characteristic analysis, 20-HETE showed the highest discriminatory ability for ALVR (AUC 0.713, 95% CI 0.594–0.833; p < 0.001), followed by platelet count (AUC 0.670, 95% CI 0.546–0.794; p = 0.007). By contrast, 15(S)-HETE and NETosis activity were not significant discriminators in the primary analyses. Overall LV function improved during follow-up, with LVEF increasing from 49.0% to 56.0% (p < 0.001). In secondary exploratory analysis, higher HDL was independently associated with LVEF improvement of ≥10% (OR 7.84, 95% CI 1.26–48.99; p = 0.028).

Conclusions

Lower platelet count and lower 20-HETE measured on the morning after PCI were independently associated with subsequent CMR-defined ALVR after first STEMI. Platelet count may serve as a simple, clinically accessible marker of risk, while 20-HETE suggests a potential role of eicosanoid-related pathways in remodeling process.

Schlagwörter

Stichwörter der Autor:innen

20-hydroxyeicosatetraenoic acidST-segment elevation myocardial infarctionbiomarkerscardiac magnetic resonanceeicosanoidsleft ventricular remodeling

Autor:innen und Institutionen

  • Institute of Cardiology, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
  • Heart Center, Medical Academy, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
  • Faculty of Medicine, Medical Academy, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.

ORCID-Profile: Vacis Tatarunas, Ieva Ciapiene, Paulius Bucius, Liepa Kleizaite, Tomas Lapinskas

Zitieren

APA

Virbickiene, A., Tatarunas, V., Ciapiene, I., Jonaitiene, N., Jureviciute, J., Bucius, P., Leleika, A., Jonauskiene, I., Kleizaite, L., Lapinskas, T., & Dobiliene, O. (2026). Clinical and Biomarker Predictors of Adverse Left Ventricular Remodeling After First STEMI: Insights into Phenotype Variability Using CMR. Pharmaceuticals, 19(5), 794. https://doi.org/10.3390/ph19050794

Vancouver

Virbickiene A, Tatarunas V, Ciapiene I, Jonaitiene N, Jureviciute J, Bucius P, et al. Clinical and Biomarker Predictors of Adverse Left Ventricular Remodeling After First STEMI: Insights into Phenotype Variability Using CMR. Pharmaceuticals. 2026;19(5):794. doi:10.3390/ph19050794

BibTeX
@article{Virbickiene2026,
  author = {Virbickiene, Agneta and Tatarunas, Vacis and Ciapiene, Ieva and Jonaitiene, Neda and Jureviciute, Justina and Bucius, Paulius and Leleika, Arnoldas and Jonauskiene, Ieva and Kleizaite, Liepa and Lapinskas, Tomas and Dobiliene, Olivija},
  title = {Clinical and Biomarker Predictors of Adverse Left Ventricular Remodeling After First STEMI: Insights into Phenotype Variability Using CMR},
  journal = {Pharmaceuticals},
  year = {2026},
  volume = {19},
  number = {5},
  pages = {794},
  doi = {10.3390/ph19050794}
}
Kostenlos starten →